Non-Antibody Products — page 1 of 44,716
Non-Antibody Products
Page 1 of 44,716
| Name | Description | Size | Catalog # | Supplier | |
|---|---|---|---|---|---|
| 88255-01-0 | Purity ≥98%. MW: 420.46 | 100 mg, 500 mg | MBS132338 |
 MYBIOSOURCE INC. |
More Info |
| 95343-20-7 | Purity ≥98%. MW: 664.1 | 100 mg, 500 mg | MBS130215 |
MYBIOSOURCE INC. |
More Info |
| 92.1 | Tissue: uvea; Tumor: melanoma, melanin production. | 1 vial | ABC-TC444S |
 ACCEGEN BIOTECH |
More Info |
| 380 | Tissue: peripheral blood; Tumor: leukemia, pre-B cell; Derived from a pati… | 1 vial | ABC-TC442S |
ACCEGEN BIOTECH |
More Info |
| 1301 | Human T-cell leukaemia. 1301 Is a sub-line of CCRF-CEM. It has unusually l… | 1 vial | ABC-TC0001 |
ACCEGEN BIOTECH |
More Info |
| 5637 | 5637 Cell line was established from the primary bladder carcinoma of a 68-… | 1 vial | ABC-TC0015 |
ACCEGEN BIOTECH |
More Info |
| 666-15 | An inhibitor of CREB-mediated gene transcription (IC50 = 81 nM in a cell-b… | 10 mg | 30780-10 |
 CAYMAN CHEMICAL COMPANY |
More Info |
| 666-15 | An inhibitor of CREB-mediated gene transcription (IC50 = 81 nM in a cell-b… | 25 mg | 30780-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 666-15 | An inhibitor of CREB-mediated gene transcription (IC50 = 81 nM in a cell-b… | 5 mg | 30780-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 666-15 | An inhibitor of CREB-mediated gene transcription (IC50 = 81 nM in a cell-b… | 50 mg | 30780-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 13323-67-6 | Purity ≥98%. MW: 286.3 | 5 mg | orb1290280 |
 BIORBYT LTD. |
More Info |
| 1360900-71-5 | MW: 228.0427 | 100 mg | orb1146568 |
BIORBYT LTD. |
More Info |
| 14787-34-9 | Purity ≥98%. MW: 358.4 | 5 mg | orb1290300 |
BIORBYT LTD. |
More Info |
| 1776-30-3 | Purity ≥98%. MW: 240.3 | 20 mg | orb1290287 |
BIORBYT LTD. |
More Info |
| 20127-63-3 | Purity ≥98%. MW: 196.2 | 20 mg | orb1290297 |
BIORBYT LTD. |
More Info |
| 408324-00-5 | Purity ≥98%. MW: 332.4 | 5 mg | orb1290294 |
BIORBYT LTD. |
More Info |
| 42206-91-7 | Purity ≥98%. MW: 372.4 | 10 mg | orb1290298 |
BIORBYT LTD. |
More Info |
| 53596-71-7 | Purity ≥98%. MW: 242.3 | 20 mg | orb1290277 |
BIORBYT LTD. |
More Info |
| 653-47 | Purity 98.00%. MW: 370.83 | 50 mg, 100 mg | orb1685345 |
BIORBYT LTD. |
More Info |
| 666-15 | 666-15 is a potent and selective CREB inhibitor with an IC50 of 81 nM. MW:… | 1 g, 100 mg, 250 mg, 10 mM * 1 mL in DMSO | orb401883 |
BIORBYT LTD. |
More Info |
| 666-15 | Purity 99.77%. MW: 620.52 | 200 mg, 100 mg, 1 mg, 50 mg, 25 mg, 10 mg, 5 mg | orb1301894 |
BIORBYT LTD. |
More Info |
| 666-15 | n/a | 5 mg, 10 mg, 50 mg | orb1889352 |
BIORBYT LTD. |
More Info |
| 8011-6561 | Purity 98.00%. MW: 291.39 | 5 mg, 50 mg, 100 mg | orb1709067 |
BIORBYT LTD. |
More Info |
| 8- | MW: 232.191 | 5 mg | orb421163 |
BIORBYT LTD. |
More Info |
| 11-10-8 | An ionizable cationic lipid; has been used in the generation of LNPs for m… | 10 mg | 40747-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 11-10-8 | An ionizable cationic lipid; has been used in the generation of LNPs for m… | 25 mg | 40747-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 11-10-8 | An ionizable cationic lipid; has been used in the generation of LNPs for m… | 5 mg | 40747-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 11-10-8 | An ionizable cationic lipid; has been used in the generation of LNPs for m… | 50 mg | 40747-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 119-23 | An ionizable cationic lipid; has been used in the generation of LNPs for t… | 1 mg | 41386-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 119-23 | An ionizable cationic lipid; has been used in the generation of LNPs for t… | 10 mg | 41386-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 119-23 | An ionizable cationic lipid; has been used in the generation of LNPs for t… | 5 mg | 41386-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 293 | n/a | n/a | 103 |
 NIH HIV REAGENT PROGRAM |
More Info |
| A 205804 | Purity ≥98%. MW: 300.39 | 100 mg, 500 mg | MBS132392 |
MYBIOSOURCE INC. |
More Info |
| A 66 | Purity ≥98%. MW: 393.52 | 100 mg, 500 mg | MBS132169 |
MYBIOSOURCE INC. |
More Info |
| A 740003 | Purity ≥98%. MW: 474.565 | 100 mg, 500 mg | MBS132187 |
MYBIOSOURCE INC. |
More Info |
| A 740003 | Purity >98%. A 740003 is a novel competitive antagonist of P2X7 receptors… | 10 mg, 25 mg, 50 mg | MBS384091 |
MYBIOSOURCE INC. |
More Info |
| A 769662 | Purity ≥98%. MW: 360.39 | 100 mg, 500 mg | MBS130892 |
MYBIOSOURCE INC. |
More Info |
| A 769662 | Purity 97%+. MW: 360.39 | 5 mg, 1ml/10mM (in DMSO), 10 mg | MBS576261 |
MYBIOSOURCE INC. |
More Info |
| A 803467 | Purity >98%. A 803467 is a selective blocker of NaV1.8 channels (IC50 valu… | 10 mg, 1 mL (in DMSO), 25 mg | MBS384093 |
MYBIOSOURCE INC. |
More Info |
| A 83-01 | Purity ≥98% by HPLC. Background: A selective inhibitor of TGF-beta type… | 1 mg | MBS842636 |
MYBIOSOURCE INC. |
More Info |
| A 83-01 | Purity ≥98%. MW: 421.52 | 100 mg, 500 mg | MBS132328 |
MYBIOSOURCE INC. |
More Info |
| A 83-01 | Purity >98%. A83-01 is a TGF-β kinase / activin receptor like kinase… | 5 mg, 10 mg, 25 mg | MBS384095 |
MYBIOSOURCE INC. |
More Info |
| A 922500 | MW: 428.48 | 5 mg | MBS8506458 |
MYBIOSOURCE INC. |
More Info |
| A 922500 | Purity ≥98%. MW: 428.488 | 100 mg, 500 mg | MBS130245 |
MYBIOSOURCE INC. |
More Info |
| A 967079 | Purity >98%. A 967079 is a selective TRPA1 channel blocker (IC50 values ar… | 10 mg, 25 mg, 50 mg | MBS384097 |
MYBIOSOURCE INC. |
More Info |
| A-1155463 | Purity >98%. A-1155463 is a highly potent and selective BCL-XL inhibitor,… | 5 mg, 10 mg, 50 mg | MBS384082 |
MYBIOSOURCE INC. |
More Info |
| A-1210477 | Purity ≥98%. MW: 886.51 | 100 mg, 500 mg | MBS131280 |
MYBIOSOURCE INC. |
More Info |
| A-1210477 | Purity ≥99%. MW: 850.04 | 2 mg, 5 mg, 10 mg | MBS575263 |
MYBIOSOURCE INC. |
More Info |
| A-1210477 | Purity >98%. A-1210477 is a potent and selective MCL-1 inhibitor. A-121047… | 5 mg, 10 mg, 25 mg | MBS384084 |
MYBIOSOURCE INC. |
More Info |
| A-1331852 | Purity ≥98%. MW: 658.82 | 100 mg, 500 mg | MBS131656 |
MYBIOSOURCE INC. |
More Info |